Andrew Tjaardstra

Deals ramp up in Asia’s healthcare space with cancer focus

An acquisition in Hong Kong by the New Frontier Group, an IPO by Sunho Biologics on the HKEX and a $1.5bn investment into Singapore by AstraZeneca, are signs that investments in next generation cancer treatments are increasing in the region.
May 28, 2024

EQT beats Asia mid-market growth fund target

The $1.6bn fundraise more than doubled the fund’s target size of $750m. The mid-market strategy will focus on the technology, services and healthcare sectors, prioritising India, SE Asia, Japan and Australia.
May 27, 2024

Carlyle closes ¥430bn Japan buyout fund

The global private equity firm's fifth Japanese buyout fund is targeting sectors including technology, media, telecoms, retail and healthcare, and is 70% larger than its previous fund.
May 22, 2024

Hong Kong Monetary Authority steps up e-CNY pilot

In order to help residents use the currency in Hong Kong, the HKMA has linked the digital currency with the Faster Payment System. In addition, corporate use cases for cross-boundary trade settlement will be explored.
May 21, 2024